Skip to main content
Livermore
Livermore
ZHEN

KBC Group NV

SEC CIK
0001411133
Latest filing
Aug 5, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by KBC Group NV, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
20,408
Value
$6.14M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ALNY by KBC Group NV, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202620,408$6.14M<0.1%−116−0.6%ReducedHolders
Q1 202620,524$6.79M<0.1%−327,670−94.1%ReducedHolders
Q4 2025348,194$138.5M0.3%+74,842+27.4%AddedHolders
Q3 2025273,352$124.6M0.3%+79,802+41.2%AddedHolders
Q2 2025193,550$63.1M0.2%+174,238+902.2%AddedHolders
Q1 202519,312$5.21M<0.1%−10,714−35.7%ReducedHolders
Q4 202430,026$7.07M<0.1%+5,460+22.2%AddedHolders
Q3 202424,566$6.76M<0.1%+9,470+62.7%AddedHolders
Q2 202415,096$3.67M<0.1%00.0%UnchangedHolders
Q1 202415,096$2.26M<0.1%+1,187+8.5%AddedHolders
Q4 202313,909$2.66M<0.1%−1,601−10.3%ReducedHolders
Q3 202315,510$2.75M<0.1%+1,390+9.8%AddedHolders
Q2 202314,120$2.68M<0.1%−13,886−49.6%ReducedHolders
Q1 202328,006$5.61M<0.1%+21,629+339.2%AddedHolders
Q4 20226,377$1.51M<0.1%−1,449−18.5%ReducedHolders
Q3 20227,826$1.57M<0.1%+172+2.2%AddedHolders
Q2 20227,654$1.12M<0.1%+215+2.9%AddedHolders
Q1 20227,439$1.22M<0.1%+200+2.8%AddedHolders
Q4 20217,239$1.23M<0.1%−7,610−51.2%ReducedHolders
Q3 202114,849$2.80M<0.1%+827+5.9%AddedHolders
Q2 202114,022$2.38M<0.1%+4,453+46.5%AddedHolders
Q1 20219,569$1.35M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.